Archive · 5 Dec 2025
Senores Pharma Gains FDA Approval in Philippines
Senores Pharmaceuticals, a company that makes medicines, just got permission from the Philippine government to sell 10 of its products there.
These medicines help with heart problems, brain and nerve issues, and pain.
The company is happy because this is a big step in their plan to sell more medicines in Southeast Asia.
The medicines they got approved are worth about $23 million in the Philippines.
The boss of the company, Swapnil Shah, said they want to make good and affordable medicines for people.
This approval also helps them sell more medicines in other parts of Asia and the Pacific.
The company's stock price was ₹778 on Friday.
Senores Pharmaceuticals received approval for 10 products in the Philippines.
The approved products cover cardiovascular, CNS, and pain-management therapies.
The combined market size for these products in the Philippines is $23 million.
The approvals support Senores' expansion strategy in Southeast Asia.
The company's stock closed at ₹778 on the last trading day.
- Who
- Senores Pharmaceuticals Ltd
- What
- Received marketing authorizations for 10 products in the Philippines
- When
- Not specified
- Where
- Philippines
- Why
- To deepen presence in Southeast Asia and broaden access to affordable treatments
- Company
- Senores Pharmaceuticals Ltd
- Regulatory Body
- Philippine Food and Drug Administration
- Products Approved
- 10
- Therapeutic Areas
- Cardiovascular, CNS, Pain Management
- Managing Director
- Swapnil Shah
- Stock Price
- ₹778 (as of Friday)